Concepedia

Kapil Saxena

KS

Statistics

Publications

24

Citations

2.9K

H-Index

20

Active since

1997

Affiliations

Daiichi Sankyo (United States)(Current)

National Cancer Center Hospital East

The University of Texas MD Anderson Cancer Center

Kindai University Hospital

Memorial Sloan Kettering Cancer Center

Kapil Saxena is an author at Daiichi Sankyo (United States) specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1997–2024

24

Publications

24

Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 886 citations · Full text

Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

Salvatore Siena, Maria Di Bartolomeo, Kanwal Raghav et al. · The Lancet Oncology · 2021 · 392 citations

, , +5

Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology

Kapil Saxena, Sarah E. Blutt, Khalil Ettayebi et al. · Journal of Virology · 2015 · 371 citations · Full text

Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections

Winnie Y. Zou, Sarah E. Blutt, Sue E. Crawford et al. · Methods in molecular biology · 2017 · 147 citations · Full text

, , +6

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav et al. · Nature Communications · 2023 · 138 citations · Full text

1–5 of 24